Trial intelligence / Profile preview

Dydrogesterone versus micronized vaginal progesterone for luteal phase support in HRT frozen embryo transfer cycles

2020-004491-17Phase 4Completed

Sponsor
UZ Brussel
Start
Jan 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of dydrogesterone and progesterone in infertility (2 arms), sponsored by UZ Brussel. Primary endpoint: Ongoing pregnancy rate at 12 weeks gestation. Started Jan 2021; status: completed.

02

Drugs

dydrogesteroneprogesterone
03

Conditions

infertility

Beyond the preview

Go deeper on 2020-004491-17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-004491-17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call